Background: Significant cardiorespiratory events are frequent in patients undergoing gastrointestinal endoscopy. Central to the occurrence of respiratory events is an unsecured airway. This study sought to determine the efficacy of a new laryngeal mask airway, the LMA
Conclusions:
The LMA ® Gastro TM Airway appears effective for clinical use in upper gastrointestinal endoscopy.
Clinical trial registration: ACTRN12616001464459.
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Upper gastrointestinal endoscopy is a common medical procedure worldwide.
1,2 Sedation with propofol is widely used and considered a safe sedation technique for upper gastrointestinal endoscopy. 3e5 However, recent evidence from a large prospective multicentre observational study in 2132 patients from university-affiliated hospitals reported a high rate of significant unplanned events in 23% of patients undergoing gastrointestinal endoscopy with propofol sedation, including a significant cardiorespiratory event in 18%. 2 With both the number and complexity of interventional upper gastrointestinal endoscopy increasing, more patients may require deep sedation, risking airway and respiratory compromise. 16 Furthermore, airway management may be difficult in patients with obesity and/or obstructive sleep apnoea. 7 This followed a standardized procedure similar to the technique described for the LMA ® Classic TM Airway. 9 The convex surface was lubricated with water-based gel before grasping the integral bite block and advancing it behind the tongue. Next, it was guided from the hard to the soft palate, down the posterior pharyngeal wall, and into the hypopharynx where resistance is felt. Here it was seated with the airway channel cuffed around the laryngeal opening and the posterior part of the device with the distal opening of the endoscopy channel directed at the upper oesophageal entrance. Effective insertion of the device was confirmed by resistance to further distal movement, manual ventilation resulting in effective chest wall movement, observing movement of the reservoir bag in response to spontaneous ventilation, and listening for gas leakage at the mouth. 10 The breathing circuit was connected to the airway channel and airway patency confirmed with manual test ventilation at 20 cm H 2 0 (water) pressure for 3 s effected by use of the adjustable pressure-limiting valve on the anaesthetic machine.
Standardized endoscope insertion
The endoscope was inserted through the lubricated endoscopy channel of the LMA ®
Gastro
TM Airway. The endoscopist gently advanced the endoscope without flexing its tip while observing progress on the monitor. Lubrication of the endoscopy channel was performed with human-compatible silicone spray before the procedure. Anaesthesia was maintained with propofol boluses with the patient breathing spontaneously an oxygen/air mixture through the airway channel. Propofol administration was discontinued at endoscopy completion. The LMA ® Gastro TM Airway was removed on spontaneous eye opening or response to verbal command.
Primary outcome

Success rate of endoscopy
This was defined as no more than three attempts to pass the endoscope into the oesophagus through the endoscopy channel of the LMA ® Gastro TM Airway. insertion was graded as 'easy' or 'difficult' by the attending anaesthetist according to the number of airway manipulations required. If more than one of the following manipulations were required, it was graded as 'difficult': (i) chin lift, (ii) jaw thrust, (iii) head extension, and (iv) neck flexion; (6) Lowest intraoperative oxygen saturation was measured using pulse oximetry; (7) Presence of a sore throat after LMA removal, reported in the postoperative recovery unit. As soon as patients were awake, they were asked, 'Do you have a sore throat?' (8) Visualization of blood on the LMA after removal; (9) Airway compromise after LMA removal defined as an event requiring airway intervention; (10) Postoperative laryngospasm defined as stridor, which may progress to complete obstruction, increased respiratory effort, tracheal tug, paradoxical respiratory effort, oxygen desaturation, or airway obstruction, not responding to oral airway insertion; (11 
Secondary outcomes
Sample size calculation
Considering an anticipated success rate at upper gastrointestinal endoscopy of 99% with a precision of 1.5%, ensuring the lower limit of the 95% confidence interval (CI) of the success rate did not decrease below 97.5%, a sample size of 292 participants was required. 13 
Statistical analysis
Data cleaning was performed by checking for data entry errors and missing data. Continuous data were evaluated for normality using the KolmogoroveSmirnov statistic (P>0.05 indicates normality) and normal quantile-quantile plots.
Normally distributed continuous data were presented as mean [standard deviation (SD)]. Skewed continuous data were presented as median [range or inter-quartile range (IQR)]. Percentages were calculated for binary outcomes. 14 The 95% CI for the binomial success percentages close to 100% were calculated using the Wilson method with continuity correction. 15 The calculation of the 95% CI was performed using a method appropriate for success percentages close to 100%, for which standard methods are inadequate because the normal approximation to the binomial distribution is poor. 15 A onesided test was chosen because the most appropriate alternative hypothesis for this research design is one-tailed, but results for a two-sided test are provided for comparison. 15 At issue was whether the lower bound of the endoscopy success rate (primary outcome) fell below 97.5%. The 95% CI for all other percentage calculations (those not near 0 or 100%) were calculated using a normal approximation to the binomial distribution. P values <0.05 were considered significant. 15 Analyses were performed using SPSS version 24 (IBM Corp., Armonk, NY, USA) and Microsoft Excel 2013 (Microsoft Corp., Redmond, WA, USA). 
Results
Patient characteristics and flow
Gastro
TM Airway insertion failures (more than three failed attempts each) out of the 292 patients enrolled into the trial, resulting in 290 patients receiving the allocated intervention (endoscopy performed through the endoscopy channel). Table 1 presents the characteristics of the 292 study participants. Table 2 presents the procedural characteristics. Of 30 participating anaesthetists, four (13%) were senior trainees and 26 (87%) fully qualified. Of the 15 participating gastroenterologists, one (7%) was a senior trainee and 14 fully qualified (93%). 
Endoscopy outcomes
As per protocol analysis (n¼290, cohort with successful LMA The present study was adequately powered with a sufficiently large sample to not only confirm statistically a high success rate, but also to detect device failures. 13 Only three (1.0%) endoscopy failures occurred during this study. The lower limit of the 95% CI of the binomial distribution for success rate of endoscopy was 98%, satisfying robust efficacy requirements. 13 Although performance of a two-sided test resulted in the lower limit of the 95% CI dipping to 97%, marginally below 97.5%, this result is not clinically significant. It is widely acknowledged that setting success or failure rates are arbitrary and subjective. 13 The primary outcome, success rate of endoscopy, was chosen, as it is unlikely that endoscopists will modify their practice unless they are satisfied that the LMA The success rate of LMA ® Gastro TM Airway insertion was excellent (99%). Calculation of the binomial 95% CI (95% CI: 98, 99) revealed that the lower limit was 98% confirming efficacy. This success rate is equivalent to the reported success rate of the LMA ® Classic TM Airway of 99%. 16, 17 Moreover, our results are consistent with the reported success rates of other commonly used second-generation supraglottic airway devices, where no more than three insertion attempts was allowed. 17e20 This result is noteworthy considering that 30 different anaesthetists performed the device insertions. A combination of experience with supraglottic device insertion and rigorous training including supervision of the first five insertions likely contributed to the high proportion of successful insertions. The lateral patient position (used in 99% of patients) was also advantageous as we found that the patient's tongue tended to fall out of the path of the dual channel LMA, facilitating successful insertion. Arterial oxygenation was maintained at or above 90% in all patients but one who had a single significant hypoxic event (SpO 2 ¼87%). This is an improvement on the reported incidence of hypoxia for upper gastrointestinal procedures, ranging between 2% and 70%. 2, 6, 21 Post-procedure, only one patient experienced airway compromise because of secretions requiring suctioning, jaw support, and supplemental oxygen. Another patient briefly experienced laryngospasm after removal of the dual channel LMA, which resolved quickly and did not require further intervention. The presence of blood on supraglottic airway devices upon removal is common. 22 One study demonstrated the occurrence of occult blood in 76% of the LMAs (n¼50) after washing them in water. Most studies report the occurrence of visible bloodstaining ranging between 0% and 50%. 10, 17, 23 The large range in these figures may be attributed to slight differences in device insertion techniques affecting minor trauma to the oropharyngeal mucosa. 24e26 Our data shows that traces of visible bloodstaining occurred in 76% (95% CI: 72, 81) of dual channel LMA devices, despite an easy insertion reported in 92% (95% CI: 90, 95) overall. This did not trigger a high incidence of laryngospasm, as previously discussed. It is noteworthy that none of the abovementioned reports included upper gastrointestinal endoscopy, which has potential for minor trauma because of oesophageal intubation. Sore throat is a common postoperative complication after supraglottic device insertion with an incidence ranging from 6% to 34%. 27e30 The LMA ® Gastro™ Airway had a slightly higher incidence of 37% (95% CI: 33, 42) . This is likely attributed to supraglottic airway sizes, skills, differences in insertion technique, and dissimilarities in the definitions of sore throat. 24 It is likely that the rate was over-reported in our study. The query was framed as a leading question 'Do you have a sore throat?' This may have prompted a positive response regardless of the severity, introducing information bias. Furthermore, this question was posed early on admission to the 
Conclusions
In patients undergoing upper gastrointestinal endoscopy, the LMA ® Gastro TM Airway yielded a high rate of endoscopy success, along with an excellent airway insertion success rate. 
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